These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17193687)

  • 41. New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer.
    Rydland J; BjØrnerud A; Haugen O; Torheim G; Torres C; Kvistad KA; Haraldseth O
    Acta Radiol; 2003 May; 44(3):275-83. PubMed ID: 12751998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30-day-old Sprague-Dawley rats, with special emphasis on mammary neoplasia.
    Stoica G; Koestner A; Capen CC
    Anticancer Res; 1984; 4(1-2):5-12. PubMed ID: 6712176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging Tumor Necrosis with Ferumoxytol.
    Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
    PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agents.
    Aref M; Brechbiel M; Wiener EC
    Invest Radiol; 2002 Apr; 37(4):178-92. PubMed ID: 11923640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of gadomelitol in a human breast tumor model in mice.
    Corot C; Robert P; Lancelot E; Martinell A; Santus R
    MAGMA; 2005 Jul; 18(3):138-43. PubMed ID: 16047191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine.
    Koktzoglou I; Harris KR; Tang R; Kane BJ; Misselwitz B; Weinmann HJ; Lu B; Nagaraj A; Roth SI; Carroll TJ; McPherson DD; Li D
    Invest Radiol; 2006 Mar; 41(3):299-304. PubMed ID: 16481913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral nerve repair: monitoring by using gadofluorine M-enhanced MR imaging with chitosan nerve conduits with cultured mesenchymal stem cells in rat model of neurotmesis.
    Liao CD; Zhang F; Guo RM; Zhong XM; Zhu J; Wen XH; Shen J
    Radiology; 2012 Jan; 262(1):161-71. PubMed ID: 22056686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase.
    Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J
    Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade.
    Brasch RC; Daldrup H; Shames D; Wendland M; Okuhata Y; Rosenau W
    Acad Radiol; 1998 Apr; 5 Suppl 1():S2-5. PubMed ID: 9561030
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of tumor angiogenesis with a second-generation US contrast medium in a rat breast tumor model.
    Ko EY; Lee SH; Kim HH; Kim SM; Shin MJ; Kim N; Gong G
    Korean J Radiol; 2008; 9(3):243-9. PubMed ID: 18525227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and Evaluation of Diindole-Based MRI Contrast Agent for In Vivo Visualization of Necrosis.
    Zhang L; Liu L; Zhang D; Jin Q; Gao M; Wu T; Feng Y; Ni Y; Yin Z; Zhang J
    Mol Imaging Biol; 2020 Jun; 22(3):593-601. PubMed ID: 31332630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell labeling with the positive MR contrast agent Gadofluorine M.
    Henning TD; Saborowski O; Golovko D; Boddington S; Bauer JS; Fu Y; Meier R; Pietsch H; Sennino B; McDonald DM; Daldrup-Link HE
    Eur Radiol; 2007 May; 17(5):1226-34. PubMed ID: 17206428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interstitial MR lymphography in mice: comparative study with gadofluorine 8, gadofluorine M, and gadofluorine P.
    Kiryu S; Inoue Y; Sheng F; Watanabe M; Yoshikawa K; Shimada M; Ohtomo K
    Magn Reson Med Sci; 2012; 11(2):99-107. PubMed ID: 22790296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.